S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

CGEM Cullinan Therapeutics Inc

10.15

-0.15 (-1.46%)

Last Updated: 13:27:18

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Cullinan Therapeutics (NASDAQ:CGEM)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Cullinan Therapeutics Charts.

Cullinan Therapeutics (NASDAQ:CGEM)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Cullinan Therapeutics Charts.

Cullinan Therapeutics Inc News

Cullinan Therapeutics to Participate in Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference
Thursday 30 January 2025 (1 week ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 29 January 2025 (1 week ago) • Edgar (US Regulatory)

Taiho Pharmaceutical, Taiho Oncology, and Cullinan Therapeutics Announce Primary Endpoint Met in Phase 2b Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Received Prior Therapy
Tuesday 28 January 2025 (1 week ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 6 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 20 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 20 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 20 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 16 December 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (3 months ago) • Edgar (US Regulatory)

Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024
Thursday 14 November 2024 (3 months ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 8 November 2024 (3 months ago) • Edgar (US Regulatory)

More Cullinan Therapeutics Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions